Company intelligence
STEMCELL Technologies
Committed to advancing science with innovative technologies and expert support.
About STEMCELL Technologies
STEMCELL Technologies is a Canadian biotechnology company that helps power leading-edge life science research around the world. Driven by our love of science and passion for quality, we are Scientists Helping Scientists—standing by our customers to provide the outstanding products, technical support, and training they need to advance their research. Scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research are among those who rely on our cell culture media, cell separation products, instruments, accessory products, and services. Since the launch of the company by Dr. Allen Eaves in 1993, STEMCELL has reinvested all profits back into the research and development of products to better support the international research community. Today, STEMCELL is the largest biotech company in Canada, with over 2000 employees globally, most with scientific or engineering degrees. Through our many regional offices, as well as our distribution centers in Vancouver, Seattle, Grenoble, and Singapore, we deliver our innovative, specialized products to more than 70 countries. At STEMCELL, we are dedicated to improving lives through advancing knowledge and scientific discovery, through our commitment to fostering diversity and inclusion in STEM and the life sciences industry, and through our investments in sustainability, community, and social responsibility. We do all this because we love science as much as you do. #ScientistsHelpingScientists
Verified activity
Signals from STEMCELL Technologies
8 published signals
Research & Knowledge
STEMCELL Technologies developed a nanomedicine platform that reprograms autoreactive T cells into regulatory cells to treat autoimmune disorders.
Reported by Dr. rer. nat. Julia Vorac
Research & Knowledge
STEMCELL Technologies published a sales myth about introverts in sales.
Reported by Ami Ashar-Patel, Ph.D.
Research & Knowledge
STEMCELL Technologies published research suggesting that women with unbalanced Lactobacillus states may have substantially higher odds of symptomatic Genitourinary Syndrome of Menopause.
Reported by Dr Josiane Chuisseu
Research & Knowledge
STEMCELL Technologies cites the McKinsey Health Institute data indicating that women spend an average of 25% more of their lives in poor health relative to men, translating to roughly nine years of life impacted by preventable or poorly managed conditions.
Reported by Dr Josiane Chuisseu
Research & Knowledge
STEMCELL Technologies cites research from the McKinsey Health Institute indicating that closing the women's health gap could boost the global economy by at least $1 trillion annually by 2040.
Reported by Dr Josiane Chuisseu
Research & Knowledge
STEMCELL Technologies cites World Economic Forum and Boston Consulting Group data indicating that women’s health captures only 6% of private healthcare investment, leaving massive, high-burden areas like cardiovascular disease, autoimmune conditions, and menopause chronically underfunded.
Reported by Dr Josiane Chuisseu
Research & Knowledge
STEMCELL Technologies established an advanced multi-cellular intestinal co-culture model that recapitulates key features of the native mucosal environment, including dendritic cell and macrophage immune activation and phenotypic shift in response to pro-inflammatory stimuli.
Reported by Dr. rer. nat. Julia Vorac
Presence & Recognition
STEMCELL Technologies is exhibiting at the PhD Program Regenerative Sciences at Medizinsche Hochschule Hannover.
Reported by Dr. Michaela Bienert, MBA